Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2022-12-02

Clinical Trial Update: Optimized-dose Amoxicillin Versus Standard-dose Amoxicillin for Quadruple Therapy in Helicobacter Pylori Eradication [Phase 4]

View source ↗

Summary

Phase 4 trial comparing an optimized-dose amoxicillin regimen to standard-dose amoxicillin within quadruple therapy for Helicobacter pylori eradication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)

Snippet

Sponsor: Les Laboratoires des Médicaments Stériles | Conditions: Helicobacter Pylori | Phase 4 | Status: COMPLETED